Company profile
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista
- CEO
- Mr. Andrew Simpson
- Headquarters
- Southlake, TX, United States
- Employees
- 14
- IPO date
- Jun 15, 2022
- Sector
- —
- Industry
- Health Care Equipment & Supplies